PEGFILGRASTIM VERSUS FILGRASTIM IN THE MANAGEMENT OF POST-CHEMOTHERAPY NEUTROPENIA IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA IN TREATMENT WITH BVD (BENDAMUSTINE BORTEZOMIB-DEXAMETHASONE)

被引：0
|
作者：
Cerchione, C. [1 ]
Nappi, D. [1 ]
Salvatore, D. [1 ]
Migliaccio, I. [1 ]
Pane, F. [1 ]
Catalano, L. [1 ]
机构：
[1] Au Federico Ii, Hematol Ematol & Trapianto, Naples, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1330
引用
收藏
页码：550 / 551
页数：2
相关论文
共 50 条
  • [21] Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM)
    Offidani, Massimo
    Corvatta, Laura
    Maracci, Laura
    Liberati, Anna Marina
    Ballanti, Stelvio
    Attolico, Immacolata
    Caraffa, Patrizia
    Alesiani, Francesco
    di Toritto, Tommaso Caravita
    Gentili, Silvia
    Tosi, Patrizia
    Brunori, Marino
    Derudas, Daniele
    Ledda, Antonio
    Gozzetti, Alessandro
    Cellini, Claudia
    Malerba, Lara
    Mele, Anna
    Andriani, Alessandro
    Galimberti, Sara
    Mondello, Patrizia
    Pulini, Stefano
    Coppetelli, Ugo
    Fraticelli, Paolo
    Olivieri, Attilio
    Leoni, Pietro
    BLOOD, 2013, 122 (21)
  • [22] BENDAMUSTINE-BORTEZOMIB-DESAMETASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Catalano, L.
    Pareto, A. E.
    Basile, S.
    Marano, L.
    Peluso, I.
    Simeone, L.
    Vitagliano, O.
    Palmieri, S.
    Rocco, S.
    Ferrara, F.
    Pane, F.
    HAEMATOLOGICA, 2017, 102 : 796 - 796
  • [23] PEGFILGRASTIM AS PROPHYLAXIS OF FEBRILE NEUTROPENIA DURING CHEMOTHERAPY OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Pugliese, N.
    Marano, L.
    Cerciello, G.
    Avilia, S.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2013, 98 : 424 - 424
  • [24] BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Pareto, A. E.
    Zacheo, I.
    Di Perna, M.
    Nappi, D.
    Peluso, I.
    Ferrara, K.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2018, 103 : S116 - S117
  • [25] Bendamustine, Bortezomib and Dexamethasone (BVD) in Patients with Relapsed-Refractory Multiple Myeloma (MM): Updated Results of a Multicenter Phase II Study
    Offidani, Massimo
    Maracci, Laura
    Corvatta, Laura
    Marina, Liberati Anna
    Ballanti, Stelvio
    Attolico, Imma
    Caraffa, Patrizia
    Alesiani, Francesco
    di Toritto, Tommaso Caravita
    Gentili, Silvia
    Tosi, Patrizia
    Brunori, Marino
    Derudas, Daniele
    Ledda, Antonio
    Gozzetti, Alessandro
    Cellini, Claudia
    Malerba, Lara
    Mele, Anna
    Felici, Stefano
    Galimberti, Sara
    Mondello, Patrizia
    Pulini, Stefano
    Coppetelli, Ugo
    Fraticelli, Paolo
    Rizzi, Rita
    Leoni, Pietro
    BLOOD, 2014, 124 (21)
  • [26] Bortezomib in combination with bendamustine and preduisone in the treatment of patients with refractory/relapsed multiple myeloma
    Poenisch, Wolfram
    Bourgeois, Malvina
    Wang, Song-Yau
    Heyn, Simone F.
    Jaekel, Nadja
    Braunert, Leanthe
    Rohrberg, Robert
    Hurtz, Hans Juergen
    Hoffmann, Franz Albert
    Schwarzer, Andreas
    Becker, Cornelia
    Al Ali, Haifa
    Niederwieser, Dietger W.
    BLOOD, 2007, 110 (11) : 799A - 800A
  • [27] Bendamustine and prednisone in combination with Bortezomib in the treatment of patients with relapsed/refractory multiple myeloma
    Poenisch, W.
    Bourgeois, M.
    Heyn, S.
    Wagner, I
    Jaekel, N.
    Rohrberg, R.
    Hurtz, H. -J.
    Schmalfeld, M.
    Assmann, M.
    Edelmann, T.
    Mohren, M.
    Hoffmann, F. A.
    Schwarzer, A.
    Hensel, G.
    Loeschke, K.
    Becker, C.
    Krahl, R.
    Al-Ali, H. K.
    Niederwieser, D.
    ONKOLOGIE, 2012, 35 : 144 - 144
  • [28] Bortezomib in combination with bendamustine and prednisone in the treatment of patients with refractory/relapsed multiple myeloma
    Poenisch, W.
    Bourgeois, M.
    Wang, S. Y.
    Heyn, S.
    Jaekel, N.
    Al Ali, H.
    Niederwieser, D.
    ONKOLOGIE, 2008, 31 : 136 - 136
  • [29] Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple Myeloma
    Reece, Donna E.
    Trieu, Young
    Masih-Khan, Esther
    Atenafu, Eshetu G.
    Chen, Christine
    Prica, Anca
    Tiedemann, Rodger
    Trudel, Suzanne
    Kukreti, Vishal
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (07): : 387 - 394
  • [30] Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
    Spencer, Andrew
    Lentzsch, Suzanne
    Weisel, Katja
    Avet-Loiseau, Herve
    Mark, Tomer M.
    Spicka, Ivan
    Masszi, Tamas
    Lauri, Birgitta
    Levin, Mark-David
    Bosi, Alberto
    Hungria, Vania
    Cavo, Michele
    Lee, Je-Jung
    Nooka, Ajay K.
    Quach, Hang
    Lee, Cindy
    Barreto, Wolney
    Corradini, Paolo
    Min, Chang-Ki
    Scott, Emma C.
    Chanan-Khan, Asher A.
    Horvath, Noemi
    Capra, Marcelo
    Beksac, Meral
    Ovilla, Roberto
    Jo, Jae-Cheol
    Shin, Ho-Jin
    Sonneveld, Pieter
    Soong, David
    Casneuf, Tineke
    Chiu, Christopher
    Amin, Himal
    Qi, Ming
    Thiyagarajah, Piruntha
    Sasser, A. Kate
    Schecter, Jordan M.
    Mateos, Maria-Victoria
    HAEMATOLOGICA, 2018, 103 (12) : 2079 - 2087
12345